3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Recurrence
1
Neoplasms, Plasma Cell
1
Multiple Myeloma
1
Lymphoma, T-Cell
1
Lymphoma, Mantle-Cell
1
Lymphoma, Extranodal NK-T-Cell
1
Lymphoma, B-Cell
1
Locally Advanced Breast Cancer
1
Hepatitis
1
Fibrosis
1
Endometrial Neoplasms
1
Carcinoma, Hepatocellular
1
Interventions
Paclitaxel
6
Carboplatin
6
Radiotherapy
5
olaparib
4
Surveys and Questionnaires
4
Cisplatin
4
Surgical Procedures, Operative
3
Sentinel Lymph Node Biopsy
3
Metformin
3
pembrolizumab
2
lenvatinib
2
durvalumab
2
dostarlimab
2
anlotinib
2
Reverse Transcriptase Polymerase Chain Reaction
2
Progesterone
2
Magnetic Resonance Spectroscopy
2
Injections
2
High-Energy Shock Waves
2
Hematologic Tests
2
Genetic Testing
2
Docetaxel
2
Blood Specimen Collection
2
Base Sequence
2
Amplified Fragment Length Polymorphism Analysis
2
vistusertib
1
serabelisib
1
pazopanib
1
palbociclib
1
onapristone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Endometrial Neoplasms
×
Clinical Protocols
×
Clear all
NCT04063072
2021-06-02
ERAS-Gyneco
Ospedale Regina Montis Regalis
Phase NA
Unknown
1,800 enrolled